Clinical Trials Logo

Stroke clinical trials

View clinical trials related to Stroke.

Filter by:

NCT ID: NCT01026896 Active, not recruiting - Clinical trials for Stroke-induced he,Iparesis in the Arm

Mental Practice Efficacy in Stroke-Induced Hemiparesis

Start date: September 2009
Phase: Phase 2/Phase 3
Study type: Interventional

This study will examine whether mentally rehearsing moving one's affected arm after stroke will improve the quality and amount of affected arm movement. The study will enroll 100 people who have experienced a stroke > 1 year ago, and who still have difficulty moving their affected wrists and hands. Eligible subjects also cannot have any implanted devices or metal above the waist. Each patient will receive 10 weeks of therapy targeting their affected arms. Half of the subjects will also be administered mental rehearsal of the exercises that they are physically performing, while the other half will be administered stroke information and information on additional exercises that they can perform targeting their affected arms. Tests of arm movement and use will be given before and after intervention, as well as 3 months after intervention, to measure response to these interventions. We will also administer brain scans before and after intervention. We hypothesize that people receiving the mantal and physical rehearsal will show larger arm movement and use changes.

NCT ID: NCT00999180 Active, not recruiting - Stroke Clinical Trials

Botulinum Toxin Type A and Kinesitherapy of Post-stroke Patients

Start date: June 2009
Phase: Phase 3
Study type: Interventional

The objective of this study is to assess if the association of botulinum toxin type A and kinesitherapy is superior to kinesitherapy and 0,9% saline for the functional performance in post-stroke patients. Hypothesis H(0): BT-A associated to kinesitherapy is not superior to kinesitherapy in the function of hemiparetic post-stroke patients. H(1): BT-A associated to kinesitherapy is superior to kinesitherapy in the function of hemiparetic post-stroke patients.

NCT ID: NCT00930280 Active, not recruiting - Stroke Clinical Trials

Genetic and Environmental Risk Factors for Hemorrhagic Stroke-GERFHS III

GERFHS-III
Start date: July 2008
Phase:
Study type: Observational

The purpose of this study is to find risk factors for hemorrhagic stroke, specifically intracerebral hemorrhage (ICH). ICH, a type of bleeding into brain tissue, is a type of stroke that can result in death or disability in a large number of people. Our study hopes to identify a specific genetic risk factor that will help identify at risk individuals and target treatment strategies.

NCT ID: NCT00909714 Active, not recruiting - Stroke Clinical Trials

Neuroregeneration Enhanced by Transcranial Direct Current Stimulation (TDCS) in Stroke

NETS
Start date: July 2009
Phase: N/A
Study type: Interventional

Testing the hypothesis that non-invasive brain stimulation by transcranial direct current stimulation (tDCS) combined with functional training in the subacute phase of first-ever stroke will enhance functional regeneration compared with a Placebo intervention.

NCT ID: NCT00863967 Active, not recruiting - Stroke Clinical Trials

Early Detection of Arteriosclerosis

Start date: October 2003
Phase: N/A
Study type: Observational

Arteriosclerosis is a common chronic disease with well known risk factors like diabetes mellitus, hypertension, dyslipidemia, adipositas and smoking, leading to severe complications like myocardial infarction, stroke or peripheral arterial occlusive disease. In addition to life-style factors there is also a genetic predisposition to develop complicated atherosclerosis. Objective: Improve individual risk prediction by clinical phenotyping and genotyping.

NCT ID: NCT00846924 Active, not recruiting - Stroke Clinical Trials

30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event

EMBRACE
Start date: May 2009
Phase: N/A
Study type: Interventional

Atrial fibrillation is the most common cardiac cause of ischemic stroke. Detecting atrial fibrillation after a stroke or TIA is critical because highly effective secondary stroke prevention therapy is available for individuals who are recognized to have atrial fibrillation. However, atrial fibrillation is likely under-diagnosed after stroke and TIA because atrial fibrillation is often difficult to detect as it is frequently paroxysmal and asymptomatic, and patients do not routinely undergo prolonged screening. The purpose of this study is to determine the diagnostic yield of a novel 30-day cardiac event monitor compared to a repeat 24-hour Holter monitor for detecting occult paroxysmal atrial fibrillation in patients with a recent ischemic stroke or TIA of undetermined etiology after completion of a standard clinical stroke work-up (including an initial negative Holter monitor.)

NCT ID: NCT00809549 Active, not recruiting - Ischemic Stroke Clinical Trials

Study to Determine The Effect of a Drug Called Neupogen on Stroke Recovery

GIST
Start date: July 2006
Phase: Phase 1
Study type: Interventional

1. Circulating bone marrow and blood vessel precursors home in to sites of ischemia and aid regeneration of injured tissue 2. Increasing the number of circulating precursors will improve in regeneration of damaged brain following ischemic stroke.

NCT ID: NCT00780533 Active, not recruiting - Stroke Clinical Trials

Changes in and Determinants of Movement Performance, Functional Status, and Health-Related Quality of Life After Stroke Rehabilitation

Start date: August 2008
Phase: N/A
Study type: Observational

A total of 144 stroke patients 6 -24 months post onset who are between 45 and 75 years old will be recruited. A randomized-blocks pretest and posttest control group design will be applied. Four groups will be involved in this project and the subjects will be stratified on two variables: impairment level of the hand and side of lesion. Randomization will be done in blocks of six and each block randomization scheme is within each stratum. Treatment regimens will be designed to ensure that patients in 4 groups receive equivalent intensity of treatment (5 days/week for 1.5 hours/day for 4 consecutive weeks) directly supervised by senior occupational therapists. Brain and movement reorganization will be evaluated with fMRI and kinematic instrument, respectively before and after the 4-week intervention period. Clinical measures on motor impairment, daily function and quality of life will be assessed before, immediately and six months after intervention. Two examiners blind to group allocation will collaborate to provide both fMRI and kinematic evaluations and one of them will administer clinical measures. Before being allowed to work with subjects, the examiner competence will be assessed by principle investigator and co-principle investigators. Multivariate analyses of covariance will be used to examine change in brain activation, kinematic variables and clinical measures as a function of intervention while controlling for pretest data, age and onset post stroke. Multiple regression models will be established to examine the possible predictor(s) for functional outcome of each rehabilitation approach. Canonical correlation analyses will be conducted to quantify the relationship between brain/motor reorganization and clinical measures.

NCT ID: NCT00776386 Active, not recruiting - Stroke Clinical Trials

Determinants and Practical Significance of Change in Motor Ability, Functional Performance, and HRQOL After Stroke

Start date: July 2008
Phase: N/A
Study type: Observational

This study has two purposes. First, the investigators will identify determinants of changes in motor ability, activities of daily living, and HRQOL after distributed Constraint-induced therapy for patients with stroke with the Chi-squared Automatic Interaction Detector (CHAID) analysis. The results will help target which types/characteristics of patients will benefit most from the intervention and may identify different determinants across different levels of outcomes. Secondly, in order to understand the extent of treatment effect in terms of clinical relevance, the investigators will examine whether the change scores on measures of motor ability, activities of daily living, and HRQOL after distributed CIT reach clinically important differences or not.

NCT ID: NCT00682695 Active, not recruiting - Stroke Clinical Trials

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

GERFHS
Start date: September 1997
Phase:
Study type: Observational

The purpose of this study is to find risk factors for hemorrhagic stroke.